A detailed history of Occudo Quantitative Strategies LP transactions in Glaukos Corp stock. As of the latest transaction made, Occudo Quantitative Strategies LP holds 4,237 shares of GKOS stock, worth $640,719. This represents 0.11% of its overall portfolio holdings.

Number of Shares
4,237
Holding current value
$640,719
% of portfolio
0.11%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$113.62 - $135.39 $481,407 - $573,647
4,237 New
4,237 $551,000
Q4 2023

Feb 14, 2024

BUY
$59.53 - $85.11 $584,108 - $835,099
9,812 New
9,812 $779,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.2B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Occudo Quantitative Strategies LP Portfolio

Follow Occudo Quantitative Strategies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

News

Stay updated on Occudo Quantitative Strategies LP with notifications on news.